Abbott launches 14 valent Pneumococcal Conjugate Vaccine (PCV-14) That Offers Broadest Protection for Children Against Pneumococcal Bacterial Infections
Mumbai, India, 27 November 2024 – Abbott, the global healthcare leader, announced today the launch of its Pneumococcal...
